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Hematopoietic stem cells (HSCs) are a subset of bone mar-
row cells that are capable of self-renewal and differentia-
tion into all blood-cell lineages.1 HSCs reside in a specific 
microenvironment known as stem cell niche, composed of 
soluble signals, neighbor cells, and extracellular matrix.2 
Two different HSC niches, namely, osteoblastic niche and 
vascular niche, are found in the bone marrow. In the osteo-
blastic niche, HSCs are associated with a subset of osteo-
blasts that line the endosteal surface of trabecular bone. In 
the vascular niche, HSCs are in close proximity to the sinu-
soidal endothelium of bone marrow. An orchestra of signals 
mediated by soluble factors and cell–cell interaction regu-
lates the balance of quiescence,3–5 self-renewal,6,7 and dif-
ferentiation of HSCs.8 Readers are directed to some 
excellent reviews on HSC niche.2,9–18
Osteoblastic cells are critical components in the osteo-
blastic niche in bone marrow. Calvi et al.6 found that activa-
tion of parathyroid hormone–related protein receptor, 
which is expressed in osteoblasts, associates with an 
increased number of HSCs and high levels of Notch ligand 
Jagged 1. Similarly, conditional ablation of bone morpho-
genetic protein receptor type IA (BMPRIA) augmented the 
number of osteoblasts with a simultaneous increase in HSC 
number.7 In contrast, a loss of HSC number was reported 
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upon osteoblastic destruction in a genetically modified 
mouse model.19 These studies indicated the important role 
of osteoblasts in controlling HSC expansion.
Mesenchymal stem/stromal cells (MSCs), character-
ized by their multidifferentiation property and ability to act 
as feeder layer for HSC culture, are another essential HSC 
niche component. Recently, it was found that immature 
osteoblasts including MSCs and preosteoblasts or osteo-
progenitors, rather than mature osteoblasts, actively par-
ticipate as HSC niche cells.2,14,20 In a multicellular spheroid 
model, undifferentiated and osteogenically differentiated 
MSCs have been shown to form an informative niche for 
HSC lodgment and proliferation.21 Moreover, HSCs are 
closely associated with nestin-expressing (nestin+) 
MSCs.22 Depletion of nestin+ MSCs caused a reduction in 
bone marrow homing of hematopoietic progenitors. 
Furthermore, MSCs expressed factors such as stem cell 
factor (SCF), vascular cell-adhesion molecule 1 (VCAM1), 
and interleukin (IL)-7 that regulated HSC proliferation, 
adhesion, and homing.22,23 Specifically, engraftment of 
HSCs is promoted upon co-transplantation of HSC and 
MSC.23 Furthermore, conditioned medium of MSC sup-
ports HSC expansion,24 while osteogenically differentiat-
ing MSC acts as feeder layer of HSC via secretion of a 
chemoattractant CXCL12.25
Apart from niche cells, extracellular matrix niche fac-
tors present in the osteoblastic niche also involved in HSC 
regulation. Osteopontin (OPN), an extracellular matrix gly-
coprotein expressed by osteoblastic cells, has a negative 
effect on HSC proliferation as demonstrated by an increase 
in HSC number in OPN-deficient mice,3,4 suggesting its 
role in maintenance of HSC quiescence. Another extracel-
lular matrix component, calcium also plays important role 
in the osteoblastic HSC niche. Calcium ions are important 
matrix niche for HSC because a high concentration of cal-
cium ions in the bone marrow endosteum attracted HSCs 
through the calcium-sensing receptor expressed on cell sur-
face, facilitating the lodgment and retention of HSC within 
the niche.26 Moreover, Ca2+ concentration also affects mor-
phology and Ang 1 expression of osteoblast in the niche.27
Despite increasing knowledge on the HSC niche, the 
roles of cellular and extracellular components as well as 
their interactions with HSCs have not been fully elucidated. 
Much of the current understanding regarding HSC niche is 
characterized by using complex and time-consuming ani-
mal models. Furthermore, cells interact with their extracel-
lular matrix differently when they are in three-dimensional 
(3D) configuration as compared with those in two-
dimensional (2D) monolayer cultures.28 These suggest that 
in vitro model that engineers and recapitulates certain com-
ponents in the HSC niche in 3D configuration is impor-
tant29 and will significantly enhance our understanding of 
multicellular and cell–matrix interactions within the niche.
We previously developed a novel collagen microencap-
sulation technology,30 which entraps bone marrow–derived 
MSCs in a self-assembled biomimetic collagen fiber mesh-
work. This collagen meshwork provides a physiologically 
relevant microenvironment for MSCs to survive, prolifer-
ate, migrate, and differentiate.31 Upon induction of differ-
entiation, committed MSCs are able to remodel the template 
collagen meshwork by depositing new extracellular matri-
ces specific to the lineages that they are differentiating 
toward. For example, chondrogenically differentiating 
MSCs derived a type II collagen, glycosaminoglycan 
(GAG), and aggrecan-rich extracellular matrix,32 while 
osteogenically differentiating MSCs remodeled the colla-
gen meshwork with osteogenic markers including alkaline 
phosphates (ALPs) and calcium phosphate nodules, pro-
ducing bone-like matrices.33 In this study, we hypothesize 
that the bone-like matrices derived from osteogenically dif-
ferentiating MSCs partially reconstitute important matrix 
niche for HSCs and represent an in vitro model for HSC 
niche studies. First, we aim to characterize the bone-like 
matrix reconstituted by osteogenically differentiating 
MSCs in collagen constructs. Second, decellularized bone-
like matrix will be compared to pure collagen scaffold in 
supporting MSC–HSC interactions. Third, antibody neu-




To produce the in vitro model for HSC niche study, a bone-
like matrix was reconstituted by osteogenically differenti-
ating MSCs microencapsulated in collagen constructs. To 
study whether the bone-like matrix supports HSC and MSC 
interactions, the matrix was decellularized before seeding 
DiI fluorescence–labeled human MSCs and then green flo-
rescence protein (GFP)-labeled HSCs for co-cultures. Pure 
collagen scaffold was used as the control matrix. The num-
ber of HSCs bound to the scaffold and the number of MSC–
HSC pairs with intimate proximity were evaluated using 
image analysis. To study the significance of BMP2 in the 
bone-like matrix, neutralizing antibody of BMP2 was sup-
plemented to the culture medium preceding and during co-
cultures before counting the number of HSC and MSC–HSC 
pairs.
Fabrication and decellularization of bone-
like matrix derived from osteogenically 
differentiating MSCs
All protocols involving animals were approved by the insti-
tutional ethical committee. Mouse MSCs (mMSCs) were 
isolated and cultured as previously described32 before 
encapsulating them in collagen constructs for subsequent 
osteogenic differentiation. In brief, bone marrow was 
flushed out from the femurs and tibias of imprinting control 
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region (ICR) mice using a 30-gauge needle and then passed 
through a 70-µm nylon mesh cell strainer (BD Biosciences, 
Franklin Lakes, NJ, USA). Cells collected after centrifuga-
tion at 400g for 10 min were cultured using Dulbecco’s 
modified Eagle’s medium–low glucose (DMEM-LG) sup-
plemented with 10% fetal bovine serum (FBS), 100 U/mL 
penicillin, 100 µg/mL streptomycin, and 2 mM l-glutamine. 
Growth medium was changed after 3 days of culture and 
replenished every 3–4 days thereafter. Cells in passage 1 
were used for microencapsulation as previously described.30 
In brief, MSC suspension at a final density of 5 × 105 cells/
mL was mixed with neutralized rat tail type I collagen solu-
tion (BD Biosciences, Bedford, MA, USA) at a final con-
centration of 2 mg/mL in an ice bath. An aliquot of 100 µL 
of the collagen–MSC mixture solution was dispensed into a 
custom-made cylindrical container with nonadhesive sur-
face made by covering ultraviolet (UV)-irradiated parafilm. 
The collagen–MSC droplets were incubated at 37°C in a 
humidified atmosphere with 5% CO2 for 1 h to allow gela-
tion before supplementing osteogenic differentiation 
medium for subsequent differentiation experiment. In order 
to derive bone-like matrices from mMSC, the cell-encapsu-
lated constructs were cultured in osteogenic differentiation 
induction medium as described previously.33 DMEM-LG 
supplemented with 10% FBS, 100 nM dexamethasone, 50 
µM l-ascorbic acid 2-phosphate, and 10 mM 
β-glycerophosphate was supplemented to culture wells 
containing the constructs for 3 weeks with regular replen-
ishment every 3 days before subsequent decellularization. 
Decellularization was then conducted to remove the 
mMSCs from the bone-like matrix for subsequent experi-
ments. Sodium deoxycholate was an effective ionic deter-
gent for solubilizing cytoplasmic and nuclear membranes.34 
Osteogenically differentiated mMSC–collagen constructs 
were decellularized with 4%, 5%, or 6% sodium (Na) deox-
ycholate for 1 h with constant agitation. The constructs 
were rinsed with phosphate-buffered saline (PBS) three 
times to remove excess detergent before subsequent evalu-
ation and cell seeding. Decellularization was optimized 
based on calcium concentration, which represents impor-
tant matrix component in the HSC niche26,27 and DNA con-
tent. Calcium deposits in the decellularized constructs were 
extracted with 1% trichloroacetic acid for 24 h before quan-
tification by calcium assay kit (BioAssay Systems, 
Hayward, CA, USA). In brief, equal volumes of Reagent A 
and Reagent B were mixed and equilibrated to room tem-
perature before use. An aliquot of 5 µL Ca2+ standard solu-
tions or samples was transferred into wells of a clear-bottom 
96-well plate, and 200 µL of working reagent was added. 
The mixture was incubated at room temperature for 3 min 
before measuring the absorbance at 612 nm. The amounts 
of Ca2+ present in the samples were determined by calibrat-
ing against the linear region of the standard curve, and 
maximal retention of calcium was used as the criteria for 
optimization. Significant removal of cellular components 
was also important for decellularization. DNA content in 
the scaffolds was measured with a fluorometric assay.35 
Briefly, the constructs were washed with PBS for three 
times to remove excess culturing medium. Papain digestion 
solution consisting of papain (300 µg/mL), l-cysteine (5 
mM), and ethylenediaminetetraacetic acid (EDTA) (5 mM) 
in phosphate buffer at pH 6.5 was used to digest the con-
structs at 60°C overnight, until the constructs were com-
pletely dissolved. The sample solutions were allowed to 
cool to room temperature. Standard DNA solutions of 0.25, 
0.5, 1, 2, 4, 8, and 16 µg/mL were prepared by serial dilu-
tion with Tris EDTA buffer (pH 7.4). Hoechst 33258 dye 
(Invitrogen Catalog number: H21491) was diluted to 8 µg/
mL with Tris NaCl EDTA buffer (pH 7.4). Aliquots of 100 
µL of standards and samples were added to the wells of a 
black 96-well plate, followed by 100 µL of the Hoechst 
dye. Fluorescence signals were measured at 346 nm for 
excitation and 460 nm for emission using a microplate 
reader (Safire2; Tecan, Mannedorf, Switzerland). The 
amounts of DNA in the samples were then computed by 
calibration against the linear region of the standard curve, 
and significant reduction of DNA was used as criteria for 
decellularization optimization.
Characterization of the bone-like matrix
Part of the osteogenically differentiated mMSC–collagen 
constructs was cryosectioned into sections of 15 µm thick 
for histological and immunohistochemical evaluation on 
successful osteogenesis. Routine hematoxylin and eosin 
(H&E) and von Kossa staining were used to reveal the mor-
phology and calcium deposition of the differentiated cells, 
respectively. In brief, slides were rehydrated by xylene and 
ethanol gradient to water, followed by 1% silver nitrate 
incubation under UV light for 1 h; 3% sodium thiosul-
fate was added afterward for 5 min and then rinsed with 
water. Nuclear fast red was used as counter stain. 
Immunohistochemistry against osterix, osteocalcin, and 
OPN were used to reveal intracellular and extracellular oste-
ogenic markers. Sections were incubated with 10 mM 
sodium citrate buffer (pH 6) at 95°C for 20 min for antigen 
retrieval. They were then incubated with rabbit polyclonal 
antibodies against osterix (Abcam, Cambridge, MA, USA), 
osteocalcin (Millipore, Billerica, MA, USA), and OPN 
(Millipore, Billerica, MA, USA) at dilutions of 1:100, 
1:200, and 1:1000, respectively. After overnight incubation 
at 4°C, sections were incubated with secondary antibody, 
biotinylated goat anti-rabbit IgG (BA-1000; Vector 
Laboratories, Burlingame, CA, USA), at a dilution of 1:400 
for osterix and 1:500 for osteocalcin and OPN for 30 min at 
room temperature. For BMP2 immunohistochemistry, sec-
tions were incubated with 0.2% hyaluronidase in PBS (pH 
7.4) at 37°C for 15 min for antigen retrieval. After overnight 
incubation at 4°C with rabbit polyclonal antibody against 
BMP2 (Abcam) at a dilution of 1:1000, sections 
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were incubated with the anti-rabbit secondary antibody at a 
dilution of 1:800 for 30 min at room temperature. The 
VECTASTAIN ABC kit (Vector Laboratories) and the 
3,3′-diaminobenzidine (DAB) substrate system (Daoko, 
Glostrup Denmark) were used for color development. Our 
previous study showed osteoinductive activity in osteogeni-
cally differentiated mMSC–collagen microspheres.33 
Secretion of BMP2 by osteogenically differentiating MSCs 
was also measured. During osteogenic differentiation of 
mMSC in collagen constructs, conditioned medium from 
each construct cultured on 24-well plate was collected dur-
ing medium replenishment. BMP2 enzyme-linked immuno-
sorbent assay (ELISA) immunoassay (Quantikine; R&D 
Systems, Minneapolis, MN, USA) was conducted after 
debris removal by centrifugation according to the manufac-
turer’s instructions. In brief, BMP2 presented in conditioned 
medium bound to monoclonal antibody pre-coated on the 
dish. A second monoclonal antibody, which is enzyme-
linked, against BMP2 was added afterward to bind the 
bound BMP2. Substrate solution was added to react with the 
linked enzyme for color development. Color intensity, 
which was proportional to BMP2 concentration, was meas-
ured by microplate reader (UVM 340; ASYS, Cambridge, 
UK). BMP2 secretion from the constructs from day 0 to 
n
n= ∑ ( )CV0 , where C is the concentration of BMP2 in 
conditioned medium and V is the volume of conditioned 
medium (fixed). In order to evaluate the ultrastructure of the 
decellularized matrix, the constructs were fixed in 2.5% glu-
taraldehyde for 2 h at room temperature, dehydrated through 
a graded series of ethanol, followed by critical point drying. 
The constructs were fractured to expose their cross sections 
for mounting and gold sputtering before examination with 
scanning electron microscope (SEM) (LEO 1530; LEO 
Electron Microscopy, Cambridge, UK).
Fabrication of pure collagen scaffold
Pure porous collagen scaffold was fabricated as previously 
described36 and was used as the control group to study 
MSC–HSC interactions. Acid soluble rat tail type I colla-
gen (Becton Dickinson) was diluted to 2 mg/mL with 0.2 M 
acetic acid to a final volume of 100 µL per construct in a 
96-well culture plate. Collagen gel was allowed to undergo 
gelation in an ammonium chamber for 30 min. After brief 
rinse and overnight incubation in sterile distilled water, the 
collagen gel was then freeze-dried at −40°C for 24 h to 
form porous collagen scaffold. The freeze-dried constructs 
were sterilized with 70% ethanol for 15 min before equili-
brating with 1× PBS prior to subsequent cell seeding.
Fluorescence labeling and seeding of human 
MSC
A human bone marrow mesenchymal stromal cell line (HS-
5; American Type Culture Collection, Rockville, MD, 
USA) was used as the niche cell for HSC in this study. Our 
separate study showed that this cell line expresses osterix 
(Supplementary Information 1), an important transcription 
factor promoting osteogenic potential of MSCs.37 They 
were cultured in growth medium containing DMEM–high 
glucose (HG), 10% FBS, 100 U/mL penicillin, and 100 µg/
mL streptomycin. Growth medium was replaced every 2–3 
days. Cells were harvested before confluence and subcul-
tured up to passage 23. Human MSCs (hMSCs) were 
labeled with fluorescent dye before seeding to either pure 
collagen scaffold or decellularized bone-like matrix. Prior 
to cell seeding, hMSCs were labeled with Vybrant® CM-DiI 
(a lipophilic vital dye) cell labeling solution (Molecular 
Probes; Invitrogen, Carlsbad, CA, USA) according to the 
manufacturer’s procedure. In brief, hMSCs were incubated 
with 1 µM labeling solution for 5 min at 37°C in a humidi-
fied atmosphere with 5% CO2 and a further 15 min at 4°C. 
Cells were rinsed with PBS twice, detached by 0.25% 
trypsin-EDTA and resuspended in growth medium for sub-
sequent seeding experiment. Both freeze-dried pure colla-
gen scaffold and decellularized constructs were washed 
with PBS and equilibrated with growth medium for 1 h 
prior to cell seeding. After removal of the medium from the 
scaffolds, 5 µL of labeled hMSCs suspension at a concen-
tration of 2.4 × 107 cells/mL was directly dropped onto each 
construct. hMSCs were allowed to adhere to the construct 
for 45 min before carefully supplementing growth medium 
for culture of 3 days before seeding HSCs for co-culture.
Isolation, culture, and fluorescent labeling of 
human HSCs
Cord blood samples were collected from healthy donors. 
All procedures were approved by the Combined Clinical 
Ethics Committee of the University of Hong Kong and 
Hong Kong West Cluster Hospitals of Hospital Authority. 
Human HSCs (hHSCs) (CD34+ cells) were isolated by 
magnetic cell sorting using magnetic beads conjugated with 
anti-CD34 antibodies (MiltenyiBiotec, Auburn, CA, USA). 
hHSCs were cultured in StemSpan® H3000 medium 
(STEMCELL Technologies, Vancouver, BC, Canada) sup-
plemented with StemSpan® H300 and StemSpan® CC110 
(STEMCELL Technologies). hHSCs were then labeled by 
electroporation using a human CD34+ cell nucleofactor kit 
(VPA-1003; Lonza, Cologne, Germany). A GFP-containing 
plasmid was electroporated into the cells using a cocktail 
with a preset program (U-008) on the electroporation 
machine (Nucleofector™ 2b device; Lonza). The transfec-
tion efficiency was around 80%.
Co-culture of hHSCs with hMSCs
After culturing the DiI-labeled MSCs on either the pure 
collagen scaffold or the decellularized bone-like scaffold 
for 3 days, hHSCs were seeded on the constructs for co-
culture. After removing all MSC culture medium, an ali-
quot of 5 µL of GFP-labeled hHSC suspension at a 
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concentration of 9.6 × 106 cells/mL was dropped onto each 
construct, giving a final hMSC to hHSC ratio of around 5:1. 
hHSCs were allowed to adhere to the scaffolds for 45 min 
before carefully supplementing hHSC growth medium for 
further co-culture of 1 and 3 days.
Tracking fluorescence-labeled hMSC in 
decellularized matrix
In order to track the location of the seeded hMSCs in the 
decellularized scaffold, DiI membrane fluorescence–
labeled hMSCs were seeded in decellularized scaffolds and 
cultured for 1 and 3 days as previously described. To distin-
guish newly seeded hMSCs from any incompletely dis-
carded osteogenically differentiating mMSCs, which also 
express the intracellular osteogenic marker osterix, co-
localization of DiI fluorescence and osterix was monitored. 
In brief, the constructs were cultured in hMSC growth 
medium for either 1 or 3 days and then fixed in 4% PBS-
buffered paraformaldehyde for cryosections. Fluorescence-
labeled hMSCs were imaged under confocal fluorescence 
microscope before processing for immunohistochemistry 
of osteogenic markers including osterix, OPN, and osteoc-
alcin as described. Fluorescent images of labeled hMSCs 
and immunohistochemistry images of osterix positivity in 
the same sections were processed using Adobe Photoshop. 
By using the “Magic Wand Tool” with a tolerance value of 
20, background of the fluorescence image was removed. 
The patterns of the fluorescent spots corresponding to 
labeled cells were then mapped to the immunopositive sig-
nals of osterix of the same sections in merged image by 
using the “Free Transform” function, during which the flu-
orescence image was resized and rotated without constrain-
ing the aspect ratio to match the respective signals.
Evaluation of the interactions between 
hHSCs and hMSCs
The distribution of hMSCs and hHSCs was visualized 
under a confocal microscopy (LSM 710; Carl Zeiss, 
Oberkochen, Germany). On days 1 and 3 of co-culture, 
confocal imaging was used to study the interactions 
between the hHSCs and hMSCs. Two constructs from each 
time point (days 1 and 3) were used for cell counting. A 
range of 3–8 views were randomly selected from each con-
struct at different Z level under confocal microscope under 
the same magnifications. Then, the number of green HSCs 
per view (and hence per unit area) was counted. For quan-
tification of cell number on the scaffolds, stack images of 
optical sections were obtained at 20× magnification, with 
objective Fluar 20×/0.75 M27. hHSCs and hMSCs with 
interactions were identified as pairs and the images were 
selected, zoomed, and exported as image file. The hHSC–
hMSC pair was defined by either co-localization of or a 
less than one-cell-diameter (10 µm) distance between the 
green hHSC and the red hMSC,7,38–42 and the number of 
such pairs per view (and hence per unit area) was also 
counted. For imaging the hHSC and hMSC “pairs,” optical 
sections were obtained at 40× magnification, with an oil 
lens (EC Plan-Neofluar 40×/1.3 oil DIC M27). All GFP sig-
nals from hHSCs were excited by Argon 488 nm laser with 
bandpass slider ranging from 493 to 546 nm. All DiI signals 
from labeled hMSCs were excited by HeNe 543 nm laser 
with bandpass slider ranging from 548 to 673 nm. Raw files 
of images were exported for subsequent image analysis by 
Imaris software (Bitplane Scientific, Zurich, Switzerland), 
in which 3D view of stack images was reconstructed and 
presented as videos.
Effects of neutralizing antibody against 
BMP2
In order to study the importance of BMP2 in MSC–HSC 
interactions, a neutralization antibody experiment was con-
ducted. In brief, decellularization should kill all osteogeni-
cally differentiating BMP2-releasing mMSCs. In order to 
assure that all BMP2 was removed during MSC and HSC 
binding and co-culture, excess neutralizing anti-human 
BMP-2/4 antibody at 2 µg/mL (R&D Systems) was supple-
mented to the HS-5 culture medium throughout 3 days of 
MSC culture period. Same amount of the antibody was then 
supplemented to the HSC culture medium throughout 3 
days of MSC–HSC binding and co-culture period. Two con-
structs from each time point (days 1 and 3) and each group 
(with and without BMP2 antibody) were used for cell count-
ing. A range of 6–9 views were randomly selected from each 
construct at different Z level under confocal microscope at 
the same magnification. Then, the number of HSCs and 
MSC–HSC pairs per view (and hence per unit area) was 
counted, using Imaris, in mMSC-derived bone-like matrices 
with and without BMP2 neutralizing antibody.
Data presentation and statistical analysis
Quantitative results such as quantity of Ca2+, DNA content, 
BMP2 secretion, and number of HSCs or HSC–MSC pairs 
were reported as mean ± 2 standard error (SE) of mean. 
Normality assumption was verified before using one-way or 
two-way analysis of variance (ANOVA) to reveal the differ-
ences among different treatment groups. A significant level 
was set as 0.05, and SPSS 19.0 was used for the analysis.
Results
Osteogenically differentiating mMSC 
remodeled the template collagen matrix
Figure 1 showed the histological, histochemical, and immu-
nohistochemical staining of osteogenic markers in mMSC–
collagen constructs exposed to osteogenic differentiation 
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medium for 21 days. Differentiating mMSCs expressed 
osteogenic marker osterix (Figure 1(b)) and remodeled the 
template matrix by depositing new extracellular matrix 
components found in bones, including osteocalcin (Figure 
1(c)), both expressed intracellularly and extracellularly, 
OPN (Figure 1(d)), which expressed extracellularly, cal-
cium deposits (Figure 1(e)), and nodules (Figure 1(a)). 
Quantitative measurement of calcium deposits extracted 
from the constructs showed that the calcium content per 
unit dry weight increased up to ˜12% (w/w) after 21 days of 
differentiation (Figure 1(f)). Moreover, Figure 1(g) showed 
that as the encapsulated mMSC committed toward osteo-
genic lineages, a major osteoinductive agent BMP2 was 
continuously released to the culture medium, echoing with 
our previous finding on the osteoinductivity of mMSC–
collagen microspheres.32
Decellularization protocol with maximal 
retention of calcium and partial removal of 
cell remnants
Different concentrations of sodium deoxycholate were 
used to decellularize the constructs, and the efficiency of 
decellularization was studied by SEM, calcium assay, and 
DNA assay. The decellularization protocol is said to be 
optimized if the physical properties of the scaffold and the 
critical extracellular matrices such as calcium, which has 
been shown to be important for HSC lodgment,26 are 
retained and cells are dead and largely removed. Figure 
2(a)–(d) showed that the cellularity of osteogenic differ-
entiating mMSC–collagen constructs was reduced after 
decellularization (Figure 2(b)–(d)). Figure 2(e)–(h) 
showed the SEM images while tiny calcium nodules were 
identified from the control (Figure 2(e)) and the lowest 
concentration of decellularization agent (Figure 2(f)), but 
hardly found in higher concentrations (Figure 2(g) and 
(h)). Fibers in 6% sodium deoxycholate group were thin-
ner (Figure 2(h)), suggesting that the collagen meshwork 
might be destructed. Figure 2(i) showed that comparing 
with the control, a significant (p = 0.05) decrease in the 
amount of DNA was found in 4% sodium deoxycholate 
group, while further decrease in DNA was not significant 
at higher concentrations. Figure 2(j) showed the calcium 
content of the decellularized scaffolds. Calcium contents 
from 4% and 5% sodium deoxycholate groups were simi-
lar to the control group, while obvious decrease was noted 
in 6% group. However, no statistical significance (p > 
0.05) was found among all groups. Decellularization with 
4% sodium deoxycholate was therefore chosen as the 
optimal concentration since the collagen meshwork and 
calcium content were best preserved while removal of 
DNA was significant.
Figure 1. Osteogenic differentiation of mMSC in collagen constructs. Histological and immunohistochemical staining of osteogenic 
differentiated mMSC in collagen construct after 21 days of culture: (a) H&E staining; (b) osterix immunohistochemistry; (c) 
osteocalcin immunohistochemistry; (d) osteopontin immunohistochemistry (inset: negative control); and (e) von Kossa staining for 
calcium deposition (red arrows: cells and regions with positive staining). (f) Bar chart showing calcium content, normalized by dry 
weight, in constructs at 7, 14, and 21 days post osteogenic differentiation and (g) bar chart showing BMP2 secretion by constructs at 
7, 14, and 21 days post osteogenic differentiation (n = 3, each with duplicates).
H&E: hematoxylin and eosin; BMP2: bone morphogenic protein 2; mMSC: mouse MSC.
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Repopulation of decellularized bone-like 
matrix with newly seeded hMSCs
Figure 3(a)–(c) showed that the extracellular matrix oste-
ocalcin (Figure 3(a)) and OPN (Figure 3(b)) were still 
retained in the decellularized matrix of osteogenic dif-
ferentiating mMSC–collagen constructs. Moreover, the 
major osteoinductive agent BMP2 was also found immu-
nopositive after decellularization (Figure 3(c)), contrast-
ing to the negative control in the inset (Figure 3(c1)). 
These results suggest that the decellularized matrix still 
retains the bone-like microenvironment. Co-localization 
of the DiI-label (pseudo color: green) of hMSCs (Figure 
3(e) and (h)) and the immunopositivity of osterix (Figure 
3(d) and (g)) were found on both days 1 and 3 after seed-
ing hMSCs to the decellularized matrix. Merged images 
(Figure 3(f) and (i)) showed that most cells found in the 
decellularized matrix are both DiI-positive and osterix-
positive, suggesting that the newly seeded hMSCs were 
repopulating in the matrix. Occasionally, cells or rem-
nants with osterix positivity but not DiI-label were iden-
tified, suggesting that further optimization of the 
decellularization protocol is necessary.
Decellularized bone-like matrix supports 
MSC–HSC interactions
Figure 4 showed the distribution of DiI-labeled hMSCs 
(pseudo color: red fluorescence) and GFP-transfected 
hHSCs in pure collagen scaffold and decellularized bone-
like matrix derived from osteogenically differentiating 
mMSC. There was less hMSCs (red) and hardly any HSC 
(green) found in pure collagen scaffolds (Figure 4(a)). 
However, in the bone-like matrix, more MSCs and MSC–
HSC pairs were identified (Figure 4(b)). Figure 4(c)–(g) 
showed that the MSC–HSC pairs were in intimate proxim-
ity within one-cell diameter, suggesting that they were 
closely interacting with each other. In some pairs, orange 
Figure 2. Decellularization of osteogenic differentiated MSC–collagen constructs with detergent at different dosages. (a–d) Routine 
H&E staining (scale bar: 100 µm); (e–h) SEM images; (a and e) without decellularization; (b and f) decellularized with 4% sodium 
deoxycholate; (c and g) decellularized with 5% sodium deoxycholate; (d and h) decellularized with 6% deoxycholate; (i) DNA content 
after decellularization (*statistical significant difference: p = 0.05); (j) calcium content per dry weight after decellularization (n = 3, 
each with duplicates).
MSC: mesenchymal stem/stromal cell; H&E: hematoxylin and eosin; SEM: scanning electron microscope.
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color, which refers to co-localization of the green HSCs and 
the red MSCs, was found (Figure 4(c) and (f)). 
Supplementary Information 2 showed the video of the 3D 
reconstructed image of HSC–MSC pair shown in Figure 
4(f). Figure 4(h) showed the mean number of HSCs and 
interacting HSC–MSC pairs per view found in each type of 
scaffold. In pure collagen scaffold, on average, there were 
only 2 ± 1.4 HSCs per unit area identified on day 1 post 
seeding where 0.4 ± 0.9 per unit area were paired up with 
MSC. On day 3 post seeding, there was hardly any HSC or 
HSC–MSC pair identified. In the decellularized bone-like 
matrices, significantly more HSCs, on average, 6.8 ± 3.4 
per unit area, were identified on day 1 post seeding, out of 
which, 1.3 ± 1.5 per unit area were HSC–MSC interacting 
pairs. On day 3 post seeding, 4.6 ± 3.2 HSCs per unit area 
were identified, out of which, 1.0 ± 1.0 HSC–MSC pairs 
per unit area were identified. Two-way ANOVA showed 
that the number of HSC lodged in the decellularized bone-
like scaffold was significantly different from that in colla-
gen scaffold (p < 0.001) while the time factor was not 
significant (p = 0.07). Similarly, two-way ANOVA showed 
that the number of HSC–MSC pairs identified in the decel-
lularized bone-like scaffold was also significantly different 
from that in pure collagen scaffold (p = 0.026) while the 
time factor was not significant (p = 0.452). These results 
suggest that the decellularized bone-like matrices sup-
ported HSCs’ attachment by increasing number of HSCs 
adhered and facilitated HSC–MSC interactions by increas-
ing the number of HSC–MSC pairs while pure collagen 
scaffolds did not.
Figure 3. Repopulation of decellularized bone-like matrix with newly seeded hMSCs. Immunohistochemistry of osteogenic 
matrix and osteoinductive markers in decellularized matrix derived from osteogenic differentiating mMSC–collagen constructs: 
(a) osteocalcin; (b) osteopontin; and (c) BMP2 (C1: negative control). Newly seeded hMSCs with co-localization of DiI-label and 
intracellular osterix after seeding for (d–f) 1 day and (g–i) 3 days; (d and g) osterix immunohistochemistry; (e and h) fluorescence 
staining of DiI-labeled hMSCs (pseudo color: green); (f and i) merged osterix immunohistochemistry and DiI-labeled hMSCs (squared 
frames: views being analyzed for co-localization; red arrows: cells and regions with double positive staining; red arrow heads: cell 
remnants without DiI from decellularization).
hMSCs: human mesenchymal stem/stromal cells; BMP2: bone morphogenic protein 2.
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Figure 4. MSC–HSC interactions on pure collagen scaffold and bone-like matrices derived from osteogenically differentiating 
MSCs. Dual-channel confocal microscopic images were captured at different magnifications for image analysis. (a) hMSCs and hHSCs 
co-cultured on pure collagen scaffolds and (b) hMSCs and hHSCs co-cultured on decellularized osteogenic differentiated mMSC–
collagen constructs (red: hMSC; green: hHSC). Representative images showing hMSC–hHSC pairs on (c–e) day 1 (scale bar: 50 µm) 
and (f–g) day 3 (scale bar: 10 µm). Bar chart showing the mean number of (h) hHSCs and (i) hHSC–hMSC pairs per unit area in pure 
collagen scaffold and decellularized bone-like constructs (n = 2, each with 3–8 views, *statistical significant difference, p < 0.001 for 
(h) and p = 0.026 for (i)).
MSC: mesenchymal stem/stromal cell; HSC: hematopoietic stem cell; hMSCs: human mesenchymal stem/stromal cells; hHSC: human hematopoietic 
stem cells.
10 Journal of Tissue Engineering
Neutralizing BMP2 antibody increases the 
number of HSCs
Figure 5 showed the qualitative and quantitative evaluation 
of HSCs and MSC–HSC pairs bound to the decellularized 
bone-like scaffold. Figure 5(a) and (b) showed that the 
number of green HSCs appeared increased over time when 
visualized. Figure 5(c) and (d) showed only a slight increase 
in the number of green HSCs over time. Figure 5(e) and (f) 
showed the bar charts of the number of HSCs and the per-
cent of MSC–HSC pairs per unit area. Without BMP2 anti-
body, 4.0 ± 0.28 (mean + 2 SE) HSCs per unit area were 
found in the scaffold on day 1 and the number increased to 
6.0 ± 3.6 per unit area on day 3. Out of these HSCs, 1.3 ± 
0.85 and 1.6 ± 0.99 HSC–MSC pairs per unit area were 
found on days 1 and 3, respectively. With BMP2 antibody, 
there were significantly more HSCs, 10 ± 0.42 per unit area 
identified in the decellularized bone-like scaffolds on day 1 
and the number slightly increased to 10.9 ± 4.3 per unit area 
on day 3. Among these HSCs, around 2.1 ± 0.28 and 2.4 ± 
2.2 per unit area were paired up with MSCs on days 1 and 
3, respectively. Two-way ANOVA showed that the number 
of HSC per unit area lodged in the decellularized bone-like 
matrix treated with BMP2 antibody was significantly dif-
ferent from that without (p = 0.02) while the time factor 
was not significant (p = 0.359). For the number of HSC–
MSC pairs per unit area identified in the decellularized 
bone-like scaffold, both the BMP2 antibody group factor (p 
= 0.316) and the time factor (p = 0.659) were not signifi-
cant. These data suggest that the presence of BMP2 in the 
osteogenic microenvironment is important in maintenance 
of HSC quiescence because removing the BMP2 signal 
through antibody neutralization resulted in significantly 
increased number of HSCs per unit area.
Discussion
Bone-like matrix partially represents 
important matrix components in the 
osteoblastic niche
A recent study reports that seeding decellularized bone with 
MSCs, the number of CD34+ HSCs increased,43 suggesting 
that the biological composition of the complex niche pre-
sent in the decellularized bone is important for MSC–HSC 
interactions. This study reports in vitro reconstitution of a 
bone-like matrix by osteogenically differentiating MSC in 
collagen constructs and demonstrates that this bone-like 
matrix represents partially the osteoblastic niche as it is 
able to support HSC adhesion and MSC–HSC interactions. 
This bone-like matrix consists of calcium phosphate depos-
its, type I collagen, OPN, and osteocalcin. It may also 
immobilize soluble bioactive factors secreted by osteogeni-
cally differentiating MSCs such as BMP2, which is an oste-
oinductive agent and may also play a role in HSC niche. 
Importance of calcium ions for cell–matrix and cell–cell 
interactions between HSCs and their niche has been 
suggested by previous studies. First, calcium-sensing 
receptor promotes the adhesion and lodgment of HSCs to 
their niche.26 Another study27 showed that calcium plays a 
significant role in regulating the cell morphology of osteo-
blasts through cell–cell and cell–matrix interactions by 
expressing Angiopoietin 1 (Ang 1) and 2 (Ang 2). Since 
Ang 1 expressed by osteoblasts activates the Tie-2 recep-
tors on HSCs, adhesion of HSCs to their niche is enhanced, 
supporting the quiescence and survival of HSCs. Similarly, 
it has been suggested that the calcium ions in the HSC 
niche might dictate the HSC location through regulation of 
HSC adhesion to collagen I.44 Corroborating with these 
studies, our results showed that the bone-like matrix derived 
from osteogenic differentiation of the MSCs encapsulated 
in collagen has significantly increased the number of HSCs 
bound to the matrix niche and the number of closely inter-
acting MSC–HSC pairs when compared to that in the pure 
collagen scaffold. This suggests that calcium and other 
matrices deposited from previous osteogenic differentia-
tion may promote the attachment and adhesion of HSCs 
onto the bone-like matrix and their binding and interactions 
with MSCs. Moreover, the importance of another bone 
extracellular matrix OPN in maintaining HSC quiescence 
has also been suggested as shown by increased HSC prolif-
eration in OPN-deficient mice.3,4 Further studies should be 
carried out to investigate the contributions of individual 
matrix components in regulating HSC lodgment, expan-
sion, and interactions with niche cells by approaches such 
as decalcification, competitive binding, or neutralization.
Importance of BMP2 signaling
BMPs are multifunctional proteins that are capable of regu-
lating fate of many cells including MSC and HSC.45–47 
BMP2 is an osteoinductive agent. Biologically active 
BMP2 is produced by osteogenically differentiating MSCs 
as shown in our previous study32 and the current report. 
BMP2 interferes with MSC function by inducing intracel-
lular signaling via BMP-activated receptors48 and hence 
plays a role in promoting the osteogenic differentiation of 
MSC as well as the differentiation of osteoprogenitor 
cells.47,49,50 These MSC-derived osteoblastic cells are 
proven to be a critical component in HSC niche43,44,51 able 
to retain HSCs in the osteoblastic niche.6,7 Particularly, 
immature osteogenic lineages have been shown to play 
more important roles in maintaining HSCs in the osteoblas-
tic niche.2,14,20 Specifically, osteoblastic cells anchor HSCs 
to the scaffold and maintain the quiescence signal of HSCs 
and hence regulating hematopoiesis.43,44,51 In this study, 
neutralization of BMP2 resulted in significantly higher 
number of HSCs retained in the scaffold, echoing with a 
previous study on conditional ablation of BMPRIA,7 which 
downregulates BMP signaling in the HSC niche and aug-
ments the number of osteoblasts with a simultaneous 
increase in HSC number.7 Therefore, our results also sug-
gest the importance of BMP signaling on HSC maintenance 
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and hence expansion. A second possible explanation is that 
blocking BMP2 may reduce the extent of seeded MSC in 
further committing to mature osteoblastic lineages, hence 
maintaining the immature or early osteoblastic niche cells, 
which have been shown to play an important role in 
supporting HSC lodgment. Further studies are warranted to 
delineate the role of BMP signaling in maintaining HSC 
niche. Moreover, apart from BMP2, other soluble factors 
secreted by MSCs such as chemokines attracting HSCs to 
bind and interact with the MSCs deserve investigation.
Figure 5. Effects of neutralizing antibody of BMP2 on MSC–HSC interactions in bone-like matrices derived from osteogenically 
differentiating MSCs. Dual-channel confocal microscopy images of MSC–HSC interactions with and without neutralizing antibody of 
BMP2 (red: MSCs; green: HSCs). Without antibody on (a) day 1 and (b) day 3 post co-culture and with antibody on (c) day 1 and (d) 
day 3 post co-culture. Bar charts showing the mean number of (e) HSCs (*statistical significant difference: p = 0.02) and (f) MSC–
HSC pairs per unit area with and without neutralizing antibody of BMP2 (n = 2, each with 6–9 views).
BMP2: bone morphogenic protein 2; MSC: mesenchymal stem/stromal cell; HSC: hematopoietic stem cell.
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Osteogenic differentiating MSC-derived 
bone-like matrix is a suitable 3D in vitro 
model to study HSC niche
Knowing that the real HSC niche in vivo is much more 
complex than what is reconstituted in the current bone-like 
matrix, this study reports a 3D model to investigate certain 
aspects of the HSC niche such as the niche cell and the 
extracellular matrix components of the niche. A few in vitro 
models have previously been used to study MSC–HSC 
interactions. First, an agarose gel allows HSC to migrate in 
and out, while MSC spheroid, osteogenic differentiated for 
1 week, co-cultured with HSC has shown increased lodg-
ment at vicinity to osteogenic-induced MSC and increased 
number of HSC lodged. Another report used PuraMatrix, a 
synthetic hydrogel made of self-assembled peptides, which 
allows quiescence maintenance and hypoxia gradient in 
HSCs.52 This work reports a bone-like microenvironment 
made by osteogenically differentiating MSCs in a type I 
collagen template, which acts as a suitable 3D in vitro 
model to study cellular and molecular events in HSC niche 
such as binding and interaction between HSCs and niche 
factors including the cell niche such as MSCs and osteo-
blastic cells derived from MSCs, the soluble niche such as 
BMP2, and matrix niche such as calcium deposits. The 
major advantage of the current in vitro model for HSC 
niche study is that the robust model allows studying of dif-
ferent niche factors including niche cells, matrix factors, 
soluble factors, and even mechanical factors as this model 
also fits to a high-throughput mechanoregulation loading 
system we previously developed.53,54
Limitations and future directions
A number of limitations in this study require future investi-
gation. First, incomplete decellularization of the osteogenic 
differentiated mMSC, as shown by the remnant DNA con-
tent in the decellularized constructs, is a limitation of this 
study. mMSC was used to derive the bone-like matrix 
because they are more readily differentiating toward osteo-
genic lineages and remodeling the collagen scaffold with 
mineralized matrix than human MSCs as shown in our previ-
ous work.33 However, incomplete decellularization increases 
the difficulty to track the fate of newly seeded hMSCs. That 
is the reason why co-localization of the fluorescence label 
and the intracellular osterix was used to track the newly 
seeded hMSCs. Further evaluations on the expression of 
human genes related to osteogenic differentiation markers 
including osterix, OPN, and osteocalcin via real-time poly-
merase chain reaction (PCR) are needed to confirm the dif-
ferentiation status of the seeded hMSCs. Second, the 
composition of the bone-like matrix reconstituted is com-
plex. Apart from type I collagen, calcium, OPN, and remnant 
BMP2, other unknown components such as the mechanical 
stiffness of the scaffold might also contribute to the 
osteogenic differentiation of human MSCs seeded and the 
subsequent MSC–HSC interactions. Therefore, proteomic 
analysis on the detailed composition of the matrix and char-
acterization of the mechanical stiffness in the in vitro model 
warrant further investigations. Third, BMP2 neutralization 
may not completely block the BMP signaling while other 
methods such as small interfering RNA (siRNA) may be 
more effective. Fourth, only short-term interacting events 
between MSCs and HSCs such as survival and intimate 
binding were investigated in this study, partly owing to the 
fact that the fluorescent dye DiI labeling the human MSCs 
would be photobleached upon long-term monitoring. Genetic 
labeling of MSCs for longer term co-culture between MSCs 
and HSCs in this model is necessary to investigate their func-
tional interactions such as colony formation assay and secre-
tion of soluble niche factors such as CXCL12. Last but not 
the least, an initial ratio of MSC:HSC of 5:1 was used in this 
study owing to the limited number of HSCs obtained. 
Different titrating ratios of MSCs to HSCs should be investi-
gated in the future to find out the optimal ratio of the niche 
cell to the stem cell facilitating MSC–HSC interactions and 
HSC activities such as lodgment and quiescence.
Conclusion
This study reports an in vitro model to study HSC niche. 
First, by osteogenically differentiating MSCs encapsulated 
in collagen constructs, a bone-like matrix partially reconsti-
tuting the cellular and matrix components of the osteoblas-
tic niche of HSCs was constructed. The differentiating 
MSCs express osteogenic markers including osterix, 
release osteoinductive agent BMP2, and remodel the scaf-
fold to a complex matrix consisting of calcium deposits, 
OPN, and osteocalcin. Second, decellularized bone-like 
matrix was better than pure collagen scaffold in supporting 
HSCs’ adhesion and intimate binding with MSCs, as shown 
by a significantly higher number of HSC and MSC–HSC 
pairs per unit area, respectively. Third, BMP2 is an impor-
tant factor for HSC lodgment and quiescence because neu-
tralizing BMP2 signal by antibody resulted in a significant 
increase in the number of HSCs per unit area.
Supplementary Information 1
Immunocytochemistry of osterix in hMSCs (HS-5): (A) 
negative control without primary antibody and (B) immu-
nopositivity of osterix with primary antibody at a dilution 
of 1:100 (scale bars: 50 µm).
Supplementary Information 2
Video showing the 3D reconstructed image of one hMSC–
hHSC pair in the decellularized bone-like matrix on day 3 
post seeding.
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